Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Short Interest Update

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) saw a large decline in short interest in October. As of October 31st, there was short interest totalling 73,800 shares, a decline of 47.8% from the October 15th total of 141,400 shares. Based on an average daily volume of 80,700 shares, the short-interest ratio is currently 0.9 days.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on EKSO. Lake Street Capital cut their price target on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, October 29th. StockNews.com assumed coverage on shares of Ekso Bionics in a report on Monday. They issued a “hold” rating for the company. Finally, HC Wainwright decreased their price target on Ekso Bionics from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Ekso Bionics stock. Kent Lake Capital LLC raised its position in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) by 322.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 596,050 shares of the company’s stock after purchasing an additional 454,892 shares during the period. Kent Lake Capital LLC owned about 3.28% of Ekso Bionics worth $811,000 at the end of the most recent reporting period. 6.42% of the stock is currently owned by institutional investors.

Ekso Bionics Stock Performance

Shares of EKSO stock remained flat at $0.77 during mid-day trading on Wednesday. The stock had a trading volume of 98,017 shares, compared to its average volume of 115,603. The firm has a market capitalization of $16.92 million, a P/E ratio of -1.18 and a beta of 1.47. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.14 and a current ratio of 2.81. Ekso Bionics has a twelve month low of $0.74 and a twelve month high of $3.13. The firm’s 50-day moving average is $1.05 and its 200-day moving average is $1.12.

Ekso Bionics (NASDAQ:EKSO) last posted its earnings results on Monday, October 28th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($0.02). The business had revenue of $4.13 million for the quarter, compared to analysts’ expectations of $6.00 million. Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%. During the same quarter last year, the business posted ($0.24) earnings per share. Research analysts anticipate that Ekso Bionics will post -0.48 EPS for the current year.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.